{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:00:33Z","timestamp":1770908433892,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The prevalence of IgE-mediated food allergy and anaphylaxis has risen rapidly in developed countries, and countries with rapid industrialization may follow. Therapies include elimination diets, Oral ImmunoTherapy, and the administration of biologics, but high serum IgE levels may preclude their use. Consequently, decreasing IgE becomes a rational approach and could be obtained by immunoapheresis. The aim of this review is to evaluate the rationale and advantages of immunoapheresis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The majority of the available adsorbers remove aspecifically all classes of immunoglobulins. Recently, IgE-specific adsorbers have been approved. Data on immunoapheresis for the treatment of allergic diseases with pathologically elevated IgE levels are emerging. In atopic dermatitis, this therapy alone seems to be beneficial. IgE-selective apheresis appears to be sufficient to reduce the risk of anaphylaxis in multiple food allergy (MFA) and, when IgE titers are high, to open the way to treatment with Omalizumab.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Prospective studies, with well designed protocols, are needed to assess the efficacy, tolerability, and cost-effectiveness of immunoapheresis in the field of food allergy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aci.0000000000000366","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T20:22:03Z","timestamp":1490732523000},"page":"227-231","source":"Crossref","is-referenced-by-count":5,"title":["Apheresis in food allergies"],"prefix":"10.1097","volume":"17","author":[{"given":"Lamia","family":"Dahdah","sequence":"first","affiliation":[{"name":"University Department of Pediatrics, Division of Allergy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Leone","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Unit of Immuno-Hematology and Transfusion Medicine, Pediatric Hospital Bambino Ges\u00f9, Rome, Vatican City, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariacristina","family":"Artesani","sequence":"additional","affiliation":[{"name":"University Department of Pediatrics, Division of Allergy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Riccardi","sequence":"additional","affiliation":[{"name":"University Department of Pediatrics, Division of Allergy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Mazzina","sequence":"additional","affiliation":[{"name":"University Department of Pediatrics, Division of Allergy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230827","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.iac.2011.11.008","article-title":"The epidemiology of IgE-mediated food allergy and anaphylaxis","volume":"32","author":"Allen","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"key":"R2-20230827","first-page":"56","article-title":"Severe anaphylaxis to sheep's milk cheese in a child desensitized to cow's milk through specific oral tolerance induction","volume":"45","author":"Tripodi","year":"2013","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"R3-20230827","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/ACI.0000000000000109","article-title":"Novel immunotherapy approaches to food allergy","volume":"14","author":"Hayen","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R4-20230827","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"key":"R5-20230827","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaci.2010.07.042","article-title":"Improvement of treatment-refractory atopic dermatitis by immunoadsorption: a pilot study","volume":"127","author":"Kasperkiewicz","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20230827","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jamadermatol.2014.2082","article-title":"IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis","volume":"150","author":"Kasperkiewicz","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R7-20230827","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1744-9987.12267","article-title":"Repetitive immunoadsorption cycles for treatment of severe atopic dermatitis","volume":"19","author":"Daeschlein","year":"2015","journal-title":"Ther Apher Dial"},{"key":"R8-20230827","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.jaci.2016.01.016","article-title":"Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis","volume":"137","author":"Reich","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R9-20230827","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2340\/00015555-2165","article-title":"Targeting IgE in severe atopic dermatitis with a combination of immunoadsorption and omalizumab","volume":"96","author":"Zink","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"R10-20230827","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1034\/j.1398-9995.2001.00141.x","article-title":"Plasmapheresis in the treatment of steroid-dependent bronchial asthma","volume":"56","author":"Ellingsen","year":"2001","journal-title":"Allergy"},{"key":"R11-20230827","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0031-1287824","article-title":"Plasmapheresis prior to omalizumab administration in a 15-year-old boy with severe asthma and very high IgE levels: sustained effect over 2 years","volume":"223","author":"Kerzel","year":"2011","journal-title":"Klin Padiatr"},{"key":"R12-20230827","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2017.02.007","article-title":"Extracorporeal IgE immunoadsorption in allergic asthma: safety and efficacy","author":"Lupinek","year":"2017","journal-title":"EBioMedicine"},{"key":"R13-20230827","doi-asserted-by":"crossref","first-page":"e1617","DOI":"10.1542\/peds.2015-1757","article-title":"IgE immunoadsorption knocks down the risk of food-related anaphylaxis","volume":"136","author":"Dahdah","year":"2015","journal-title":"Pediatrics"}],"container-title":["Current Opinion in Allergy &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130832-201706000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T02:15:57Z","timestamp":1693102557000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201706000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0000000000000366","relation":{},"ISSN":["1528-4050","1473-6322"],"issn-type":[{"value":"1528-4050","type":"print"},{"value":"1473-6322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}